The Food and Drug Administration (FDA) has approved 2 additional vial sizes of Niktimvo ™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size. Niktimvo, a colony stimulating ...
Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...
The contents of a confiscated bag that was labeled ‘definitely not a bag full of drugs.’ According to police, it was, in fact, a bag full of drugs. (Brevard County Sheriff’s Office ...
The treatment was approved in 2024 for chronic graft-vs-host disease after failure of at least 2 prior lines of systemic therapy in patients weighing at least 40kg. The Food and Drug ...
Brevard County Sheriff's Office However, deputies discovered that Acri had several bags with her, one of which with the label "Definitely Not A Bag Full Of Drugs." Teryn Acri was arrested in ...
The New England Patriots need a whole lot of help this offseason, and on both sides of the ball. However, their biggest needs are certainly on offense. More particularly, the Patriots are in dire ...
Jada Pinkett Smith‘s metaphorical answer to all of her problems has rubbed some fans the wrong way, and now they’re claiming she’s the root cause of all her issues. The actress’s recent ...
BECKLEY, W.Va. — An FBI chemist who tested a vial found in accused murderer Natalie Cochran’s refrigerator after the death of her husband testified Friday what was in the vial was consistent ...
a hit to his reputation and a decrease in his brand's value before his contract renegotiation with the record label this year. The suit added that UMG "understood the recording's inflammatory and ...
The FDA has approved Incyte’s and Syndax’s Niktimvo (axatilimab-csfr) in 9 mg and 22 mg vial sizes for the treatment of chronic graft-versus-host disease (GVHD) in adults and pediatric patients ...
Axatilimab has gained FDA approval in 9 mg and 22 mg vials, expanding treatment options for patients with chronic GVHD after 2 prior therapy failures. The FDA has granted approval to axatilimab-csfr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback